Merck and Sigma-Aldrich announced that they have entered into a definitive agreement under which Merck will acquire Sigma-Aldrich for $17.0 billion (€13.1 billion), establishing one of the leading players in the $130 billion global life science industry. Merck will acquire all of the outsta ... more
Heinrich Emanuel Merck Award 2012 granted to Professor Aaron Wheeler
13-08-2012: Merck announced that the 2012 Heinrich Emanuel Merck Award for Analytical Science will be given to Professor Wheeler from the University of Toronto for his development of a digital microfluidic method for the extraction and quantification of estrogen in 1-microliter samples of breast tissue homogenate, whole blood and serum. This method may be broadly applicable for diagnostics requiring frequent analysis of hormones in clinical samples, which are important markers for example in infertility or cancer. The award, endowed with € 15,000, will be presented to Professor Wheeler at Merck Millipore’s Technology Exposition in Bedford, Massachusetts, USA, on October 17, 2012.
“Professor Wheeler`s development of new analytical methods using digital microfluidic technology to overcome the limitations of conventional techniques in the extraction and quantification of estrogen is an outstanding scientific achievement with significant societal impact, for example in breast cancer diagnosis,” explained Professor Reinhard Niessner (Technical University of Munich, Germany), the head of the international jury for the Heinrich Emanuel Merck Award.
“By selecting Aaron Wheeler, we are recognizing a talented and very successful scientist. We are looking forward to his award lecture in October,” said Dr. Thomas Geelhaar, Chief Technology Officer Chemicals at Merck. “Thanks to his groundbreaking scientific approach, Professor Wheeler has helped to achieve tremendous advances in the research field of hormone analysis.”
Aaron R. Wheeler (37) is an Associate Professor at the University of Toronto, Department of Chemistry. The Wheeler research group is developing hybrid methods that rely on the unique advantages of microchannels and digital microfluidics for applications in the areas of chemistry, biology, and medicine.
Merck announced that its biopharmaceutical division Merck Serono is well on track with the implementation of the Group’s “Fit for 2018” transformation and growth program. This is reflected by efficiency gains and the successful execution of growth initiatives as well as progress in the pipe ... more
Merck Serono announced that Belén Garijo, President & Chief Executive Officer of Merck Serono, has been appointed asan independent Director of L’Oréal for a period of four years. The appointment of Belén Garijo as a new member of the Board of Directors ofL’Oréal was approved by shareholders ... more
Merck Millipore presents a groundbreaking solution: COD cell tests which can tolerate unlimited chloride content more
The Scepter™, the industry's first handheld, automated cell counter represents a breakthrough for life science researchers more
This unique fully-embedded water purification system software has been developed especially for the pharmaceutical, biotech and contract labs more
- 1Schleicher & Schuell has been purchased by Whatman plc
- 2LAUDA founds subsidiary in Italy
- 3LGC rebrands reference standards
- 4The shadow of a disease
- 5New microscope collects dynamic images of the molecules that animate life
- 6Carl Zeiss Grants Sublicense for LED Fluorescence Excitation to Prior Scientific Ltd.
- 7Towards future lab-on-chip applications
- 8Sartorius Opens New Application Center in Shanghai
- 9Pathogens in foods: progress and challenges
- 10Failed Alzheimer’s test shows in which direction the research should continue